| [1] |
HAO Xiao, ZHAO Mei, WANG Wenjing, ZHANG Feifei, LIU Huiliang, DANG Yi, LI Shuren, QI Xiaoyong.
Application of sodium-glucose cotransporter 2 inhibitors in acute myocardial infarction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 824-831.
|
| [2] |
CHEN Manxin, ZHANG Bingyu, DAI Min.
Clinical efficacy of intracoronally targeted recombinant human urokinase combined with percutaneous coronary intervention (PCI) in acute myocardial infarction (AMI) with high thrombus burden
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 544-549.
|
| [3] |
PENG Juan, LI Ranyi, FAN Linlin, LI Xiaoyu, LV Qianzhou, ZOU Yunzeng.
Progress of pharmacotherapy for myocardial hypertrophy and cardiac remodeling
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 382-389.
|
| [4] |
XIE Mengdie, WANG Chenchen, LI Bingtao, OUYANG Changsheng, QIU Yumei, LI Hongming, TU Jun, SHANG Guangbin, TANG Xilan.
Analysis on mechanism of frankincense volatile oil in prevention and treatment of cardiac hypertrophy based on in vitro cell experiment and network pharmacology
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 241-252.
|
| [5] |
FU Xiaomei, HUO Ran, DENG Sai, LIN Chaojin, FAN Jinghao, WANG Ping, LI Songpei, QIN Aiping, ZOU Minghui, YU Xiyong.
Exosomes derived from LPS-stimulated bone marrow mesenchymal stem cell improve myocardial inflammation and fibrosis after myocardial infarction in mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(8): 841-851.
|
| [6] |
ZHUO Fengqiao, HUANG Zhanhong, LIU Yujie.
Protective effect of Liquiritigenin on H9C2 cardiomyocytes apoptosis induced by high glucose
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(2): 147-151.
|
| [7] |
WANG Zheng, WANG Hegui.
Research progress of A-kinase-anchoring protein mediated regulation of cardiac hypertrophy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(11): 1304-1308.
|
| [8] |
ZONG Qiao-feng, CHENG Xiang-yang, YU Ying, ZHANG Wei-ping, GAO Qin, LI Zheng-hong.
Experimental study of endomorphin-1 postconditioning against myocardial ischemia reperfusion injury in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(2): 132-137.
|
| [9] |
ZHOU Yong, HUANG Song-qun, XU Fei.
Efficacy on slow bleeding and safety of using tirofiban before and during emergency PCI in patients with acute ST-segment elevation myocardial infarction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(11): 1268-1271.
|
| [10] |
PAN Da-bin, WANG Min-hui, CAO Heng.
Research progress of pathogenesis of diabetic cardiomyopathy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(7): 831-836.
|
| [11] |
CHEN Gao-yong, ZHANG Yan-mei, SHI Gang-gang.
Effects of extracellular-signal regulated kinsae signaling pathway on myocardial ischemia/reperfusion injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(2): 234-240.
|
| [12] |
DENG Shao-xiong, GUO Nan-ou, ZHENG-Yuan, HUANG Wen-sen.
Effect and clinical significance of tirofiban on serum matrix metalloproteinase 9 after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction and diabetes
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(7): 807-811.
|
| [13] |
BAI Xia, GUO Zhi-hong, ZHANG Fan, FAN Shu-duo.
Effects of short-term fasting on energy metabolism and arrhythmia after myocardial ischemia/reperfusion in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(8): 900-905.
|
| [14] |
TANG Yuan-yuan, TANG Bo-jian, YAN Xiao-wei, FANG Quan.
Clinical features and prognosis of obstructive and non-obstructive hypertrophic cardiomyopathy patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(2): 195-198.
|
| [15] |
XIE Ming-Ming, WANG Xin-Fang, ZHU Xiang-Ming, YANG Ya, LU Qing, CHEN Li-Xin, NIE Shao-Ping, JIANG Jue-Quan, CAO Lin-Shen.
Effects of transmyocardial laser revascularization combined with basic fibroblast growth factor on myocardial viability and cardiac function in dog models with acute myocardial ischemia1
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(2): 149-154.
|
